Marex Group Ltd (MRX) is offering senior unsecured Autocallable Contingent Income (with Memory) Barrier Notes linked to the worst performing of the Invesco QQQ Trust, the iShares Russell 2000 ETF and the S&P 500 Index, each with a $1,000 principal amount and expected to be listed on the Vienna MTF.
The Notes pay a monthly contingent coupon of 0.93% of principal (11.16% per annum, or $9.30 per $1,000) only if on each Coupon Determination Date all three underlyings are at or above 80% of their Initial Values; missed coupons may be paid later if the trigger is again met. The Notes are automatically called if, on specified quarterly Call Observation Dates, each underlying is at or above 100% of its Initial Value, in which case investors receive principal plus the applicable coupon. If not called, at maturity on September 27, 2029, investors receive principal plus the final coupon if the worst performer is at or above 80% of its Initial Value, principal only if it is at or above 60% but below 80%, and otherwise a loss matching the negative return of the worst performer, up to a complete loss of principal.
The Estimated Initial Value on the trade date (September 24, 2026) is expected to be between $940 and $990 per $1,000 Note, below the price to public, reflecting embedded costs and Marex’s internal funding rate. The underwriting discount to Marex Capital Markets Inc. is up to $6 per $1,000, and the Notes are subject to Marex’s credit risk and limited secondary market liquidity.
Marex Group Ltd (MRX) is offering $500,000 principal amount of 5.00% Callable Notes due September 25, 2028 under its shelf registration. The Notes are senior unsecured debt of Marex, issued in $1,000 denominations and priced at $1,000 per Note (or $996 for certain fee-based accounts).
The Notes pay 5.00% per annum, with interest payable semi-annually in arrears on March 23 and September 23, starting March 23, 2027, using a 30/360 day count. Marex may redeem the Notes, in whole, at 100% of principal plus accrued interest on any interest payment date from September 23, 2027 through March 23, 2028, creating reinvestment risk for investors. Application has been made to list and trade the Notes on the Vienna Multilateral Trading Facility.
The offering is distributed by Marex Capital Markets Inc. with a $4.00 per $1,000 underwriting discount, resulting in $498,000 in proceeds to Marex. Key risks include Marex’s credit risk, potential early redemption, lack of guaranteed secondary market liquidity, built-in costs that may depress secondary prices, and potential conflicts of interest as Marex affiliates act as calculation agent and market-maker.
Marex Group Ltd (MRX) is issuing $500,000 of 5.85% Callable Notes due September 23, 2031 under its shelf registration. Each note has a $1,000 principal amount and pays 5.85% fixed interest per year, with semi-annual payments on March 23 and September 23 starting March 23, 2027.
The notes are senior unsecured debt of Marex and are expected to be in book-entry form. Marex may redeem the notes early at 100% of principal plus accrued interest on any interest payment date from September 23, 2027 through March 23, 2031, which introduces reinvestment risk. Application has been made to list the notes on the Vienna Multilateral Trading Facility.
The notes are subject to Marex’s credit risk and are not insured or guaranteed by any government or third party. The public offering price is $1,000 per note, with an underwriting discount of $5 per note, resulting in $497,500 in proceeds to Marex before expenses. The pricing supplement highlights limited liquidity, potential conflicts of interest with Marex affiliates, and U.S. tax treatment as fixed rate debt instruments.
Marex Group Ltd (MRX) is issuing $2,000,000 of senior unsecured structured notes: Autocallable Contingent Income (with Memory) Barrier Notes linked to the worst performer of QQQ, IWM and the S&P 500 Index, maturing September 20, 2029. Each Note has a $1,000 principal amount and is offered at 100% of face value, with Marex receiving $994 per Note after a $6 underwriting discount.
The Notes pay a monthly Contingent Coupon of 0.959% (11.508% per annum) per $1,000 only if all three underlyings are at or above their Coupon Triggers, set at 80% of Initial Value; missed coupons may be paid later under a memory feature. The Notes may be automatically called quarterly if all underlyings are at or above 100% of Initial Value, returning principal plus coupon.
If not called, principal repayment depends on the worst-performing underlying at maturity: full principal plus final coupon if its decline is no worse than 20%; full principal (no coupon) if decline is between 20% and 40%; and 1‑for‑1 downside loss below the 60% Barrier Value, up to a total loss of principal. The Estimated Initial Value is $989 per Note, below the $1,000 issue price. The Notes are subject to Marex credit risk, may be illiquid even if listed on the Vienna MTF, and provide no ownership or dividends in the referenced ETFs or index.
Marex Group Ltd (symbol: MRX) is the issuer of record for a Form 424B2 filing submitted to the SEC.
Marex Group Ltd (MRX) reported that officer Paolo Tonucci, Chief Strategist and CEO, Capital Markets, sold 16,666 Ordinary Shares on September 14, 2026 in two open-market transactions under a Rule 10b5-1 plan entered into on October 22, 2025.
The sales were executed at weighted average prices of $70.77 and $71.35 per share across specified price ranges. Remaining holdings include 220,746 shares underlying deferred bonus plan awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.
Marex Group Ltd (MRX) reported that its President, Simon Van Den Born, sold a total of 15,271 Ordinary Shares on September 14, 2026 in open-market transactions under a Rule 10b5-1 trading plan adopted on June 12, 2026. The reported holdings associated with this filing include deferred bonus plan awards that are settled in ordinary shares upon vesting.
Marex Group Ltd (MRX) received a Form 144 notice indicating that officer Simon Van Den Born may sell up to 75,455 shares of common stock through Goldman Sachs & Co. LLC under Rule 144. The shares relate to equity compensation awards.
The notice discloses that the shares were acquired as Restricted Stock Units granted on May 4, 2023, March 11, 2025, and May 17, 2024, all from the issuer as compensation. The sales are to be made pursuant to a selling plan dated June 12, 2026 intended to comply with Rule 10b5-1(c).
Marex Group Ltd (symbol: MRX) is the issuer of record for a Form 424B2 filing submitted to the SEC.
Marex Group Ltd (MRX) is offering senior unsecured Autocallable Contingent Income (with Memory) Barrier Notes linked to the worst performing of the Invesco QQQ Trust, iShares Russell 2000 ETF and S&P 500 Index, each issued in $1,000 principal amount and scheduled to mature on September 20, 2029.
The notes pay a monthly contingent coupon of $9.59 per $1,000 (0.959% per month, 11.508% per annum) only if on each determination date all three underlyings are at or above their Coupon Trigger of 80% of initial value, with a “memory” feature that can pay missed coupons later. The notes are automatically called if, on specified quarterly observation dates from December 2026, each underlying is at or above 100% of its initial value, returning principal plus the applicable coupon.
If the notes are not called, principal repayment at maturity depends on the “Worst Performing Underlying.” If its final level is at or above 80% of initial, investors receive principal plus the final coupon; if between 60% and 80%, principal only; if below 60%, repayment is reduced 1-for-1 with the loss in the worst performer, up to a 100% loss of principal. The Estimated Initial Value on the trade date is expected to be between $940 and $993 per $1,000 note, less than the price to the public, and the notes are subject to Marex credit risk and limited liquidity, with an application for listing on the Vienna MTF.